Yi Miao
Oklahoma State University(US)Jiangsu Academy of Agricultural Sciences(CN)Longgang Central Hospital(CN)Duke Medical Center(US)Jiangsu Cancer Hospital(CN)Jiangsu Province Hospital(CN)Zhejiang University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Immune Cell Function and Interaction, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Genetic alterations and their clinical implications in DLBCL(2019)220 cited
- → Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress‐independent growth inhibition of pancreatic cancer cells through G2/M cell‐cycle arrest and apoptosis(2010)183 cited
- → Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL(2019)176 cited
- → Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age(2015)106 cited
- → B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma(2018)94 cited
- → Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies(2021)87 cited